The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Apolipoprotein L-I is the trypanosome lytic factor of human serum
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581
SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
Guex, N., & Peitsch, M. C. (1997) · ELECTROPHORESIS · doi:10.1002/elps.1150181505 · Cited by 11,241
A VSG Expression Site–Associated Gene Confers Resistance to Human Serum in Trypanosoma rhodesiense
Van Xong, H., Vanhamme, L., Chamekh, M., Chimfwembe, C. E., Van Den Abbeele, J., Pays, A., Van Meirvenne, N., Hamers, R., De Baetselier, P., & Pays, E. (1998) · Cell · doi:10.1016/s0092-8674(00)81706-7 · Cited by 362
Self-citationApolipoprotein L, a New Human High Density Lipoprotein Apolipoprotein Expressed by the Pancreas
Duchateau, P. N., Pullinger, C. R., Orellana, R. E., Kunitake, S. T., Naya-Vigne, J., O'Connor, P. M., Malloy, M. J., & Kane, J. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25576 · Cited by 227
Self-citationA structural motif in the variant surface glycoproteins of Trypanosoma brucei
Blum, M. L., Down, J. A., Gurnett, A. M., Carrington, M., Turner, M. J., & Wiley, D. C. (1993) · Nature · doi:10.1038/362603a0 · Cited by 211
Salmon, D., Geuskens, M., Hanocq, F., Hanocq-Quertier, J., Nolan, D., Ruben, L., & Pays, E. (1994) · Cell · doi:10.1016/0092-8674(94)90574-6 · Cited by 176
Killing of Trypanosomes by the Human Haptoglobin-Related Protein
Smith, A. B., Esko, J. D., & Hajduk, S. L. (1995) · Science · doi:10.1126/science.7716520 · Cited by 163
Monajemi, H., Fontijn, R. D., Pannekoek, H., & Horrevoets, A. J. G. (2002) · Genomics · doi:10.1006/geno.2002.6729 · Cited by 160
The Human Apolipoprotein L Gene Cluster: Identification, Classification, and Sites of Distribution
Page, N., Butlin, D., Lomthaisong, K., & Lowry, P. J. (2001) · Genomics · doi:10.1006/geno.2001.6534 · Cited by 143
Duchateau, P. N., Pullinger, C. R., Cho, M., Eng, C. S., & Kane, J. P. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31171-8 · Cited by 134
Self-citation
Cited by
Initial sequence of the chimpanzee genome and comparison with the human genome
The Chimpanzee Sequencing and Analysis Consortium (2005) · Nature · doi:10.1038/nature04072 · Cited by 2,459
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Genovese, G., Friedman, D. J., Ross, M. D., Lecordier, L., Uzureau, P., Freedman, B. I., Bowden, D. W., Langefeld, C. D., Oleksyk, T. K., Uscinski Knob, A. L., et al. (2010) · Science · doi:10.1126/science.1193032 · Cited by 2,028
“rhodesiense can infect humans because of a serum resistance-associated protein (SRA) that interacts with the C-terminal helix of ApoL1 and inhibits its anti-trypanosomal activity (18,22).”
The Genome of the African Trypanosome Trypanosoma brucei
Berriman, M., Ghedin, E., Hertz-Fowler, C., Blandin, G., Renauld, H., Bartholomeu, D. C., Lennard, N. J., Caler, E., Hamlin, N. E., Haas, B., et al. (2005) · Science · doi:10.1126/science.1112642 · Cited by 1,631
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481
New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
Lewis, G. F., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000170946.56981.5c · Cited by 1,093
Regulatory evolution of innate immunity through co-option of endogenous retroviruses
Chuong, E. B., Elde, N. C., & Feschotte, C. (2016) · Science · doi:10.1126/science.aad5497 · Cited by 1,008
Cholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport
Rosenson, R. S., Brewer, H. B., Davidson, W. S., Fayad, Z. A., Fuster, V., Goldstein, J., Hellerstein, M., Jiang, X.-C., Phillips, M. C., Rader, D. J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.066589 · Cited by 953
APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
Kopp, J. B., Nelson, G. W., Sampath, K., Johnson, R. C., Genovese, G., An, P., Friedman, D., Briggs, W., Dart, R., Korbet, S., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011040388 · Cited by 855
Practice parameter for the diagnosis and management of primary immunodeficiency
Bonilla, F. A., Khan, D. A., Ballas, Z. K., Chinen, J., Frank, M. M., Hsu, J. T., Keller, M., Kobrynski, L. J., Komarow, H. D., Mazer, B., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.04.049 · Cited by 791
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784
“The described variants are very common in AAs, but absent in chromosomes of European origin.(531) ApoL-I is a serum factor that lyses trypanosomes, but increased risk for CKD is the downside of having variants of this parasite-slaying protein and may thus contribute to the higher rates of renal disease in AAs.”
BackgroundAPOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease
Parsa, A., Kao, W. H. L., Xie, D., Astor, B. C., Li, M., Hsu, C.-Y., Feldman, H. I., Parekh, R. S., Kusek, J. W., Greene, T. H., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310345 · Cited by 784
Detecting Natural Selection in Genomic Data
Vitti, J. J., Grossman, S. R., & Sabeti, P. C. (2013) · Annual Review of Genetics · doi:10.1146/annurev-genet-111212-133526 · Cited by 694
Barrett, M. P., Burchmore, R. J., Stich, A., Lazzari, J. O., Frasch, A. C., Cazzulo, J. J., & Krishna, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14694-6 · Cited by 656
Tzur, S., Rosset, S., Shemer, R., Yudkovsky, G., Selig, S., Tarekegn, A., Bekele, E., Bradman, N., Wasser, W. G., Behar, D. M., et al. (2010) · Human Genetics · doi:10.1007/s00439-010-0861-0 · Cited by 653
Practice parameter for the diagnosis and management of primary immunodeficiency
Bonilla, F. A., Bernstein, I. L., Khan, D. A., Ballas, Z. K., Chinen, J., Frank, M. M., Kobrynski, L. J., Levinson, A. I., Mazer, B., Nelson, R. P., et al. (2005) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)61142-8 · Cited by 521
Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1
Nichols, B., Jog, P., Lee, J. H., Blackler, D., Wilmot, M., D'Agati, V., Markowitz, G., Kopp, J. B., Alper, S. L., Pollak, M. R., et al. (2015) · Kidney International · doi:10.1038/ki.2014.270 · Cited by 355
Shah, A. S., Tan, L., Long, J. L., & Davidson, W. S. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r035725 · Cited by 351
Apolipoprotein L-I Promotes Trypanosome Lysis by Forming Pores in Lysosomal Membranes
Pérez-Morga, D., Vanhollebeke, B., Paturiaux-Hanocq, F., Nolan, D. P., Lins, L., Homblé, F., Vanhamme, L., Tebabi, P., Pays, A., Poelvoorde, P., et al. (2005) · Science · doi:10.1126/science.1114566 · Cited by 339
Self-citationDesquesnes, M., Dargantes, A., Lai, D.-H., Lun, Z.-R., Holzmuller, P., & Jittapalapong, S. (2013) · BioMed Research International · doi:10.1155/2013/321237 · Cited by 279
The trypanosome flagellar pocket
Field, M. C., & Carrington, M. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2221 · Cited by 277
Szempruch, A. J., Sykes, S. E., Kieft, R., Dennison, L., Becker, A. C., Gartrell, A., Martin, W. J., Nakayasu, E. S., Almeida, I. C., Hajduk, S. L., et al. (2016) · Cell · doi:10.1016/j.cell.2015.11.051 · Cited by 275
APOL1 Nephropathy: From Genetics to Clinical Applications
Friedman, D. J., & Pollak, M. R. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.15161219 · Cited by 270
APOL1 Variants Associate with Increased Risk of CKD among African Americans
Foster, M. C., Coresh, J., Fornage, M., Astor, B. C., Grams, M., Franceschini, N., Boerwinkle, E., Parekh, R. S., & Kao, W. H. L. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013010113 · Cited by 267
The trypanolytic factor of human serum
Pays, E., Vanhollebeke, B., Vanhamme, L., Paturiaux-Hanocq, F., Nolan, D. P., & Pérez-Morga, D. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1428 · Cited by 172
Self-citationMolina-Portela, M. P., Samanovic, M., & Raper, J. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071463 · Cited by 88
Samanovic, M., Molina-Portela, M. P., Chessler, A.-D. C., Burleigh, B. A., & Raper, J. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000276 · Cited by 76
Functionality of HDL: Antioxidation and Detoxifying Effects
Karlsson, H., Kontush, A., & James, R. W. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-319-09665-0_5 · Cited by 55
Ljunggren, S. A., Levels, J. H. M., Hovingh, K., Holleboom, A. G., Vergeer, M., Argyri, L., Gkolfinopoulou, C., Chroni, A., Sierts, J. A., Kastelein, J. J., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.09.006 · Cited by 19
Mouse protein coding diversity: What’s left to discover?
Lilue, J., Shivalikanjli, A., Adams, D. J., & Keane, T. M. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1008446 · Cited by 19
“Some alleles confer resistance to Trypanosoma brucei brucei in humans but at the same time lead to chronic kidney disease [33].”
Background
Metadata
- Authors
- Vanhamme, L., Paturiaux-Hanocq, F., Poelvoorde, P., Nolan, D. P., Lins, L., Van Den Abbeele, J., Pays, A., Tebabi, P., Van Xong, H., Jacquet, A., Moguilevsky, N., Dieu, M., Kane, J. P., De Baetselier, P., Brasseur, R., & Pays, E.
- Venue
- Nature
- Published
- 2003-03
- Volume
- 422
- Issue
- 6927
- Pages
- 83-87
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1999030993
- Cited by
- 500
- References
- 18
- FWCI
- 13.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.